PolyPeptide Group AG Capital Reinvestment Ratio
PolyPeptide Group AG capital reinvestment ratio. PolyPeptide Group AG (PPGN) has a Capital Reinvestment Ratio of 0.98x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF49.66 Million) in capital expenditures (CHF48.68 Million). See PolyPeptide Group AG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PolyPeptide Group AG (2018–2024)
Capital reinvestment ratio of PolyPeptide Group AG from 2018 to 2024. This chart tracks PolyPeptide Group AG's Capital Reinvestment Ratio across 7 annual periods. See PPGN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
PolyPeptide Group AG Capital Reinvestment Ratio by Year (2018–2024)
PolyPeptide Group AG capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see PPGN cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.97x | CHF89.40 Million | CHF86.97 Million | ▼ -37.4% |
| 2023 | 1.55x | CHF36.48 Million | CHF56.73 Million | ▼ -89.2% |
| 2022 | 14.43x | CHF5.46 Million | CHF78.76 Million | ▲ +964.7% |
| 2021 | 1.35x | CHF57.35 Million | CHF77.71 Million | ▲ +65.0% |
| 2020 | 0.82x | CHF49.48 Million | CHF40.62 Million | ▲ +131.6% |
| 2019 | 0.35x | CHF55.60 Million | CHF19.70 Million | ▼ -55.6% |
| 2018 | 0.80x | CHF22.94 Million | CHF18.30 Million | — |